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ABSTRACT
Although obesity is a global epidemic, the physiological mechanisms
involved are not well understood. Recent advances reveal that
susceptibility to obesity can be programmed by maternal and
neonatal nutrition. Specifically, a maternal low-protein diet during
pregnancy causes decreased intrauterine growth, rapid postnatal
catch-up growth and an increased risk for diet-induced obesity. Given
that the synthesis of the neurotransmitter 5-hydroxytryptamine (5-HT)
is nutritionally regulated and 5-HT is a trophic factor, we hypothesised
that maternal diet influences fetal 5-HT exposure, which then
influences development of the central appetite network and the
subsequent efficacy of 5-HT to control energy balance in later life.
Consistent with our hypothesis, pregnant rats fed a low-protein diet
exhibited elevated serum levels of 5-HT, which was also evident in the
placenta and fetal brains at embryonic day 16.5. This increase was
associated with reduced levels of 5-HT2CR, the primary 5-HT receptor
influencing appetite, in the fetal, neonatal and adult hypothalamus. As
expected, a reduction of 5-HT2CR was associated with impaired
sensitivity to 5-HT-mediated appetite suppression in adulthood. 5-HT
primarily achieves effects on appetite by 5-HT2CR stimulation of pro-
opiomelanocortin (POMC) peptides within the arcuate nucleus of the
hypothalamus (ARC). We show that 5-HT2ARs are also anatomically
positioned to influence the activity of ARC POMC neurons and that
mRNA encoding 5-HT2AR is increased in the hypothalamus of
in utero growth-restricted offspring that underwent rapid postnatal
catch-up growth. Furthermore, these animals at 3 months of age are
more sensitive to appetite suppression induced by 5-HT2AR agonists.
These findings not only reveal a 5-HT-mediated mechanism
underlying the programming of susceptibility to obesity, but also
provide a promising means to correct it, by treatment with a 5-HT2AR
agonist.
KEY WORDS: Serotonin, Developmental programming,
Hypothalamus, Low birth weight, Maternal diet, Protein restriction
INTRODUCTION
Nutrition during critical periods of development in early life can
exert profound, long-term effects on susceptibility to obesity. For
example, men exposed to the Dutch ‘Hunger Winter’ in utero
during early gestation had an increased risk of developing obesity as
adults, whereas obesity rates were reduced amongst those exposed
to famine during the last trimester of gestation and in early postnatal
life (Ravelli et al., 1976). The early postnatal diet is also important.
In randomised trials, full-term infants with low birth weight fed a
growth-promoting nutrient-enriched formula had a higher fat mass
at the age of 5-8 years than those fed standard formula (Singhal
et al., 2010). Studies in rodents, showing that low birth weight
followed by rapid postnatal growth is associated with increased
adiposity, support findings in humans (Plagemann et al., 1992;
Cottrell et al., 2011; Berends et al., 2013). Despite these robust
associations, the molecular mechanisms mediating the interaction
between early nutrition and obesity risk are still largely unknown.
It is widely acknowledged that the hypothalamus, which in
humans develops primarily prenatally but in rodents develops
postnatally, plays an important role in the programming of body
mass (Grove et al., 2005; Horvath and Bruning, 2006; Glavas et al.,
2007). To date, major efforts have been directed at understanding
the roles of leptin and insulin in this process (Bouret, 2010; Yura
et al., 2005; Steculorum and Bouret, 2011). However, studies in our
laboratory using leptin-deficient ob/ob mice demonstrated that
leptin-independent mechanisms are likely to also programme body
mass (Cottrell et al., 2011).
The importance of the 5-hydroxytryptamine (5-HT; serotonin)
system in the control of food intake and body mass has been
recognised for many years and alterations in central serotonergic
activity have been observed in obese humans, non-human primates
and rodents (Mori et al., 1999; De Fanti et al., 2001; Sullivan et al.,
2010). 5-HT is a potent anorectic signal that influences food intake
in the mature brain by acting predominantly via 5-HT2CR to regulate
the key energy balance mediator, pro-opiomelanocortin (POMC),
within the arcuate nucleus of the hypothalamus (ARC; Doslikova
et al., 2013; Burke et al., 2014). Indeed, disruption of the 5-HT2CR
gene (Htr2c) specifically expressed on POMC neurons programmes
hyperphagia and obesity when animals are fed a high-fat diet
(Berglund et al., 2013). In addition to playing an important role in
energy balance and body mass, 5-HT acts as a trophic factor during
fetal brain development in rodents, regulating cell migration,
proliferation, maturation and axonal growth (Whitaker-Azmitia
et al., 1996; Gaspar et al., 2003). The long-term effects of
disturbances in the 5-HT system during early life on obesity risk
are, however, not fully defined.
Here, we used an unbiased genome-wide profiling approach to
identify differentially expressed targets in the hypothalamus of
intrauterine protein-restricted rats that underwent postnatal catch-upReceived 28 October 2015; Accepted 7 January 2016
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growth (recuperated animals) in an effort to elucidate the molecular
mechanisms that mediate the effects of early nutrition on energy
balance.
RESULTS
Growth trajectories, body and brain mass
At birth, offspring of mothers fed a low protein diet during
pregnancy were significantly smaller than the control pups
(P<0.001) (Table 1A). The body mass of the recuperated pups
caught up with that of control pups by postnatal day (P)14 and they
weighed the same as controls at weaning (Table 1A). Fractional
growth rate did not differ between recuperated and control pups
between birth and P7 (0.16±0.1 vs 0.17±0.01); however,
recuperated offspring had significantly higher fractional growth
rate between birth and P14 and P21 when compared with controls
(P14: 0.31±0.01 vs 0.24±0.01, P<0.001; P21: 0.38±0.01 vs 0.29±
0.01, P<0.001). At 3 months of age, body masses were similar
between recuperated and control offspring. Brain masses were
similar between the experimental animals and their age-matched
controls at both P22 and 3 months of age, in both absolute terms and
relative to body mass (Table 1B). These findings demonstrate that
maternal low-protein diet decreases in utero growth of the offspring
so that they have a lower birth weight. These animals then undergo
‘catch up’ growth such that by P22, they have the same bodymass as
the control offspring.
Levels of 5-HT and tryptophan in mothers and offspring
Maternal, placental and amniotic fluid 5-HT and tryptophan levels
Tryptophan is an essential amino acid and is required for 5-HT
synthesis. A low-protein diet would therefore be expected to yield low
plasma tryptophan levels. We analysed the levels of 5-HT and
tryptophan in the dams, placenta and amniotic fluid to investigate
whether 5-HT might be a programming factor that mediates changes
in appetite and susceptibility to diet-induced obesity in recuperated
animals.As expected, at embryonic day (E)16.5,we observed reduced
levels of tryptophan in the serumof dams fed a low-protein diet (‘low-
protein’) compared with control dams (158±17 mmol l−1 vs 220±
20 mmol l−1, P<0.05). Paradoxically, the serum 5-HT level was
raised in low-protein dams at this time point (P<0.05; Fig. 1A). A
similar pattern was observed for tryptophan and 5-HT concentrations
in the amniotic fluid at E16.5, with tryptophan levels reduced in the
amniotic fluid from low protein pregnancies (26.3±3.2 mmol l−1 vs
40.6±3.4 mmol l−1, P<0.01, n=10-11 per group), whereas 5-HT
levels were raised (65.0±6.6 nmol l−1 vs 48.2± 3.9 nmol l−1, P<0.05,
n=10-11 per group). 5-HT levels were also significantly increased in
E16.5 placentas from low-protein pregnancies when compared with
control pregnancies (P<0.01; Fig. 1A). Furthermore, we observed a
negative correlation between placental 5-HT level andmaternal serum
tryptophan (P<0.05; Fig. 1B). There was a positive correlation
between placental 5-HT and fetal brain 5-HT levels (Fig. 1C). These
findings reveal that in response to significantly reduced dietary
tryptophan, 5-HT is overproduced in themother and in the intrauterine
environment in which the fetus grows and develops.
Fetal, neonatal, weaning and adult tryptophan and 5-HT levels
Likewise, in the neonatal brain, a decrease in tryptophan levels
(67.9±13.6 mmol l−1 vs 140±14.7 mmol l−1, P<0.01) was associated
with an increase in 5-HT levels in the hypothalami of recuperated pups
at birth (P<0.01; Fig. 1A). 5-HT levelswere also increased in thebrains
of E16.5 fetuses from low-protein pregnancies (Fig. 1A). By weaning
as well as at 3 months, hypothalamic 5-HT levels were normalised to
control levels (P21: recuperated, 1347±110 mmol l−1 vs control,
1659±131 pmol g−1; n=12 per group; 3 months: recuperated,
1414±154 mmol l−1 vs control, 1354±85 pmol g−1; n=10 per
group). These data indicate that the overproduction of 5-HT in
response to a maternal low-protein diet is normalised by weaning.
Effect of D-fenfluramine on food intake
We next assessed the significance of maternal diet-stimulated
increase in 5-HT during early development of the offspring for
the function of the adult 5-HT system. D-fenfluramine is a
pharmacological probe of the endogenous 5-HT system that works
by stimulating endogenous 5-HT release and blocking its reuptake.
D-fenfluramine was prescribed until the 1990s for human obesity
treatment because increasing endogenous 5-HT bioavailability
reduces appetite and body weight (Lam et al., 2010; Marston
et al., 2011).We administeredD-fenfluramine into the third ventricle
of rats at 3 months and observed the expected reduction in food
intake in controls (Fig. 2). However, recuperated offspring had
impaired sensitivity to the 5-HT-stimulated (D-fenfluramine) food
intake reduction (P<0.05) (Fig. 2). These results show that a low-
protein maternal diet followed by accelerated postnatal growth
diminishes 5-HT-mediated control of food intake in the adult
offspring. Given the strong inverse correlation between 5-HT and
appetite, these findings led us to hypothesise that a deregulated 5-HT
system might contribute to the programmed increased food intake in
these offspring when exposed to an obesogenic diet.
Fetal, neonatal and postnatal expression of Htr2c in the
hypothalamus
5-HT is a neurotransmitter that communicates appetite-related
signals primarily through the 5-HT2CR within the ARC. If the
effects of 5-HT on appetite are diminished in recuperated rats, this
suggests a perturbation in signalling at the 5-HT2CR.We next probed
the consequence of elevated 5-HT during development on the
expression of the 5-HT2CR. Analysis ofHtr2cmRNA expression in
E16.5 fetal brain showed significantly reduced levels in the whole
heads of fetuses from low-protein pregnancies (P<0.05; Fig. 3A). At
birth, theHtr2c transcript level was still reduced in the hypothalamus
of the growth-restricted pups (P<0.001; Fig. 3A) as was 5-HT2CR
protein (P<0.001; Fig. 3B,C). However, by 3 months, no significant
differences in mRNA levels were observed between the
Table 1. Growth trajectories, body and brain mass in offspring exposed
in utero to maternal low-protein diet that underwent accelerated
postnatal growth
A. Growth trajectory during postnatal life
Body mass (g)
Control Recuperated
P3 7.4±0.3 6.2±0.2***
P7 15.9±0.8 13.4±1.1*
P14 32.0±1.1 32.5±1.4
P21 52.2±1.4 55.5±1.4
B. Body and brain mass after weaning
Control Recuperated
Body mass at 3 months (g) 417±9.0 417±7.9
Brain mass at P22 (g) 1.33±0.11 1.42±0.02
Brain mass at P22 (% of total body mass) 2.90±0.08 2.77±0.08
Brain mass 3 months (g) 2.00±0.03 1.97±0.05
Brain mass 3 months (% of total body
mass)
0.48±0.01 0.47±0.01
Data analysed using Student’s t-test. Values are expressed as means±s.e.m.
n=10 per group, *P<0.05; ***P<0.001.
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experimental groups (Fig. 3A). Protein expression was, however,
still significantly reduced in the hypothalamus of recuperated
animals at 3months (P<0.05; Fig. 3B,C). Given that perturbations of
ARC5-HT2CR function increases appetite and bodymass (Berglund
et al., 2013), these results reveal a potential mechanism through
which rapid postnatal growth is achieved in recuperated rats, which
could also contribute to increased susceptibility to diet-induced
obesity in these animals.
Microarray analysis of ARC from control and recuperated
3-month-old offspring
5-HT is a trophic factor during fetal brain development influencing
both 5-HT circuits and the anatomical organisation of other systems
(Whitaker-Azmitia et al., 1996; Gaspar et al., 2003). The ARC is a
crucial regulator of energy balance. Having demonstrated that
maternal diet induces changes in offspring 5-HT and disrupts the
functioning of the 5-HT appetite system, we next probed whether
5-HT disrupts other ARC genes and circuits regulating appetite. To
achieve this, we performed laser-capture microdissection (LCM) of
the ARC of 3-month-old control and recuperated rats and subjected
samples to microarray analysis.
Validation of laser-capture microdissection
To ensure the specificity of the ARC dissection within the LCM
material (Fig. 4), we analysed the expression of two genes that are
not expressed in the ARC but are expressed in the neighbouring
hypothalamic nuclei. Neither Brn1 (also known as Pou3f3), which
is specific to the paraventricular nucleus (PVN) nor Sf-1 (also
known as Nr5a1), which is found in the ventromedial nucleus of the
hypothalamus (VMN), were detected (data not shown). In addition,
we examined the expression of four key genes involved in the
regulation of energy balance in the ARC: Pomc, Agrp, Cartpt and
Npy. We confirmed that all of these genes were highly expressed in
the dissected material using Taqman RT-PCR (data not shown).
Analysis of microarrays using three different algorithms and pathway
analysis
Following global transcriptional profiling, we analysed the data
using three different algorithms: (1) GeneChip operating software
(GCOS), (2) robust multi-array averaging (RMA) and (3) GeneChip
robust multi-array averaging (GCRMA), to ensure maximum
stringency and to reduce the number of false positives. The
combined analysis, using a 1.3-fold cut-off threshold and P<0.05,
revealed that out of 31,099 genes analysed, expression of 15,951
genes was detected in the ARC. Of these, 142 genes were
upregulated in the ARC of the recuperated animals, whereas 59
genes were downregulated (Fig. 4B,C, respectively). The top 25 up-
and downregulated genes in recuperated offspring are presented in
Tables 2 and 3. Htr2a, which encodes 5-HT2AR, was the gene with
the highest (2.55-fold) increase. We further analysed the microarray
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Fig. 1. Effects of maternal nutrition on 5-HT levels in low-protein and control pregnancies, and neonatal pups. (A) 5-HT levels in maternal serum, the
placenta, fetal brain (all analysed at E16.5) and neonatal hypothalamus. Data analysed using unpaired Student’s t-test and presented as mean percentage of
control; for maternal serum 5-HT, n=6; placenta 5-HT, n=16; fetal brain 5-HT, n=10; neonatal hypothalamus, n=12 per group. (B,C) Correlation betweenmaternal,
placental and fetal 5-HT levels. (B) Correlation between placental 5-HT and maternal serum tryptophan, analysed using Pearson correlation coefficient because
data were normally distributed; n=6 per group. (C) Correlation between placental 5-HT and fetal head 5-HT analysed using Spearman correlation coefficient
because data were not normally distributed. n=10 per group; n represents number of litters. *P<0.05; **P<0.01.
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data using Ingenuity Pathway analysis software to detect groups of
functionally related genes. The top three gene functions affected by
early nutrition in 3-month-old male recuperated rats were cell cycle,
connective tissue development and function, cellular growth and
proliferation (Table 4).
Validation of genes identified by microarray
Out of the seven genes chosen for validation, two genes had very
low expression (Plau and Pde4a). Out of five genes remaining,
differential expression of three genes (Htr2a,Khsrp and Retsat) was
confirmed by RT-PCR, whereas two genes were not validated (Car8
and Eef2k) (Fig. 5A). As Htr2a had the highest fold change in the
microarray analysis (Table 2), it was further investigated. The
upregulation of Htr2a in the ARC of 3-month-old recuperated
animals (P<0.05) observed using RT-PCR was confirmed by in situ
hybridisation (P<0.05; Fig. 5B).
Timing and location of increased hypothalamic Htr2a
expression
A similar pattern of Htr2a expression to that seen in 3-month-old
animals was observed at P22.Htr2awas significantly elevated in the
ARC of recuperated rats at weaning (P<0.05; Fig. 5C). Expression
of Htr2a was, however, not altered in neonatal ARC (Fig. 5C) or in
E16.5 fetal brains (low-protein, 0.933±0.035; control, 1.002±
0.022). As in the ARC, expression of Htr2a was also significantly
increased in VMN of 3-month-old recuperated animals (P<0.05;
Fig. 5D,E). However, in contrast to the ARC, no difference was
seen in Htr2a expression within VMN between the two
experimental groups at P22 (Fig. 5E), suggesting that
upregulation of Htr2a within the VMN in the recuperated group is
secondary to the upregulation of this receptor in the ARC. Overall,
these findings reveal a change in 5-HT2AR receptor expression
using an unbiased genome-wide profiling approach and thereby
support the importance of maternal diet in inducing changes in the
5-HT system within the offspring hypothalami that may deregulate
offspring energy balance.
Neuronal colocalisation of ARC 5-HT2AR and POMC
Within the ARC, 5-HT primarily influences energy balance by
5-HT2CR stimulation of POMC neuronal activity (Heisler et al.,
* ***
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Fig. 3. Effects ofmaternal protein restriction on centralHtr2cmRNAand 5-HT2CRprotein expression in the offspring. (A)Htr2cmRNA levels asmeasured
using qRT-PCR. Gene expression data was normalised to Ppia. (B) Analysis of 5-HT2CR protein levels from western blot data. (C) Western blots. 20 mg and
10 mg of pooled samples were loaded in the middle of the gels to ensure the linearity of the signal. Data were analysed using unpaired Student’s t-test and
presented as mean±s.e.m. for RNA data and percentages relative to control for protein data; n=8 per group, n represents number of litters. *P<0.05; ***P<0.001.
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Fig. 2. Effects of maternal protein restriction on food intake in 3-month-
old offspring following central administration of D-fenfluramine (Dex).
Food consumption during the 2 h following lights out expressed as a
percentage of the saline dosed group. Difference between the groups analysed
by one-way ANOVA to saline for control and recuperated offspring. n=6 per
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was administered at 250 nmoles in 2.5 μl of saline. *P<0.05 for control Dex
versus recuperated Dex. ***P<0.001 for control saline versus control Dex.
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2002; Xu et al., 2008; Berglund et al., 2013; Burke et al., 2014).
Given thatHtr2a expression is reduced in rats exposed to a maternal
low-protein diet, we hypothesised that Htr2a might therefore be
upregulated to compensate for this in an effort to normalise energy
balance. To determine whether 5-HT2ARs are anatomically
positioned to influence the activity of POMC neurons, we
visualised co-expression using dual histochemical labelling. We
determined that∼40% of the ARC POMC neurons expressHtr2a in
control rats (Fig. 5F). These data reveal a defined population of
neurons within the ARC involved in regulation of body mass that
could be influenced by Gq-protein coupled 5-HT2ARs.
Effect of 5-HT2AR agonism on food intake
To assess the functional implications of upregulated ARC Htr2a
expression, we administered the selective 5-HT2AR agonist
TCB2 [(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl) methylamine
hydrobromide] directly into the third ventricle and measured its
effects on food intake in adult 3-month-old recuperated and control
offspring. We confirmed previous results showing that 5-HT2AR
agonism significantly suppresses food intake (Fox et al., 2010).
TCB2 also significantly decreased food intake in the recuperated
offspring, as shown by two-way ANOVA analysis (overall effect of
TCB2 administration, P<0.001; Fig. 6). However, the dose-
response curves between the control and recuperated groups were
significantly different (P<0.05; Fig. 6). Recuperated offspring were
more sensitive than the controls to the centrally administered action
of 5-HT2AR agonist TCB2 (overall effect of early nutrition, P<0.05;
Fig. 6). These results reveal that overexpressed 5-HT2ARs in
recuperated rats are functional and when pharmacologically
stimulated, a greater net effect on appetite is achieved.
Extrapolation of these findings to endogenous 5-HT activity, as
indicated by the D-fenfluramine results, suggests that the
upregulation of 5-HT2AR is insufficient to compensate for
downregulation of 5-HT2CR in the regulation of appetite by 5-HT.
DISCUSSION
Evidence from epidemiological studies and animal models shows
that suboptimal early nutrition affects susceptibility to obesity in
later life.We and others have shown that rodents exposed tomaternal
protein restriction in utero and accelerated postnatal growth
(recuperated offspring) are more susceptible to development of
diet-induced obesity (Ozanne et al., 2004; Bieswal et al., 2006). In
the current study, we focused on 3-month-old recuperated rats fed a
chow diet that are a similar weight to control offspring. This enabled
us to investigate mechanisms mediating the effects of early nutrition
on susceptibility to developing diet-induced obesity without the
confounding effects of obesity itself. In recent years, leptin has been
studied as a key factor involved in programming of obesity risk
(Cripps et al., 2009; Bouret et al., 2004). However, we previously
showed that programming of increased adiposity is, at least in part,
independent of leptin (Cottrell et al., 2011). In the current study, we
investigated the effect of amaternal low-protein diet during gestation
on a factor directly impacted by reduced dietary protein, 5-HT. We
observed that 5-HT levels were increased in the fetal brains and
neonatal hypothalami of rats exposed to a low-protein diet in utero.
Because 5-HT is known as an essential growth and regulatory factor
that drives the development and maturation of its own cellular
network and related neuronal systems (Pino et al., 2004; Oberlander,
2012), an excess of 5-HT might lead to impaired interneuron
migration and abnormal development of the serotonergic system
itself and its target regions (Pino et al., 2004; Oberlander, 2012).
Here, we suggest that elevated hypothalamic levels of 5-HT in
Fig. 4. Laser-capture microdissection (LCM) of the
hypothalamic ARC of 3-month-old rats and
microarray analysis results. (A) LCM of the ARC
(−4.52 to −2.30 mm relative to Bregma). Brain atlas
image was taken from Paxinos and Watson (1998). 3V,
3rd ventricle; ArcD, arcuate nucleus, dorsal part; ArcL,
arcuate nucleus, lateral part; ArcM, arcuate nucleus,
medial part; DMC, dorsomedial nucleus, compact part;
DMD, dorsomedial nucleus, dorsal part; DMV,
dorsomedial nucleus, ventral part; MEI, internal layer;
MEE, median eminence, external layer; Pe,
periventricular hypothalamic nucleus; PH, posterior
hypothalamic nucleus; PeF, perifornical nucleus; TC,
tuber cinereum area; VMHC, ventromedial nucleus,
central part; VMHDM, ventromedial nucleus,
dorsomedial part; VMHVL, ventromedial nucleus,
ventrolateral part. (B,C) Venn diagrams showing the
effects of maternal protein restriction followed by catch-
up growth on the expression of genes in the ARCof male
3-month-old offspring, according to three different,
robust, analyses: GeneChip operating software (GCOS),
GeneChip robust multi-array averaging (GC-RMA) and
robust multi-array averaging (RMA). Genes were
considered to be up- or downregulated if the 1.3-fold
threshold was reached and P<0.05. (B) Upregulated
genes and (C) downregulated genes in the recuperated
animals when compared with controls. The sizes of
circles and numbers in parentheses indicate the number
of genes as identified by either the GCOS, RMA or GC-
RMA algorithms. For microarray analysis n=6 chips per
group, n represents number of litters.
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recuperated animals in early life cause developmental and functional
alterations that increase susceptibility to obesity later in life.
We observed reduced maternal circulating tryptophan but
increased 5-HT in pregnant dams fed a low-protein diet. This
could be a consequence of (1) the increased carbohydrate content in
the low-protein diet, which was added to balance protein reduction
to obtain an isocaloric diet and (2) the dams’ increased food intake
in both absolute and relative terms (Fernandez-Twinn et al., 2003).
Such dietary intervention can affect maternal insulin levels. Low-
protein dams were shown to be hyperinsulinaemic at day 14 of
pregnancy (Fernandez-Twinn et al., 2003). As circulating
tryptophan levels decrease in an insulin-dose-dependent manner,
the increased insulin concentration in these dams could contribute to
the reduced tryptophan levels (Fernandez-Twinn et al., 2003;
Fukagawa et al., 1987). Another possibility is that the dietary
intervention has altered the gastrointestinal microbiome of the dam.
Diet is the key regulator of both taxa and microbiota production of
metabolites (Scott et al., 2013). More than 90% of 5-HT in the body
is synthesised in the gut, and the microbiota has been shown to play
a crucial role in regulating host 5-HT biosynthesis and 5-HT blood
levels (Yano et al., 2015).
Table 2. Genes in the ARC that are upregulated in recuperated 3-month-
old male rats
Probe set
ID
Fold
change
Gene
symbol Gene name
1387752_at +2.55 Htr2a 5-hydroxytryptamine
(serotonin) receptor 2A
1379905_at +1.91 Gtpbp1 GTP binding protein 1
1377472_at +1.78 Extl1 Exostoses (multiple)-
like 1
1389755_at +1.71 Cdca7l Cell division cycle
associated 7 like
1376525_at +1.69 Khsrp KH-type splicing
regulatory protein
1393134_at +1.69 Sephs1 Selenophosphate
synthetase 1
1394434_at +1.68 Snf1lk2 SNF1-like kinase 2
1383843_at +1.66 Hlcs Holocarboxylase
synthetase
1377726_at +1.59 Trim25 Tripartite motif-
containing 25
1381410_at +1.58 Fgd5 FYVE, RhoGEF and PH
domain containing 5
1383606_at +1.56 Tc2n Tandem C2 domains,
nuclear
1379817_at +1.53 Purg Purine-rich element
binding protein G
1371356_at +1.51 Tenc1 Tensin like C1 domain
containing
phosphatase (tensin 2)
1370806_at +1.51 Retsat Retinol saturase (all trans
retinol 13,14
reductase)
1378776_at +1.50 Pou6f1 POU class 6 homeobox 1
1395261_at +1.49 Snrp70 U1 small nuclear
ribonucleoprotein
polypeptide A
1369601_at +1.49 Nyw1 Ischemia related factor
NYW-1
1381919_at +1.48 Hps6 Hermansky-Pudlak
syndrome 6
1396053_at +1.47 Nedd9 Neural precursor cell
expressed
1378282_at +1.47 Csnk2a2 Casein kinase 2, alpha
prime polypeptide
1389632_at +1.46 Rhobtb1 Rho-related BTB domain
containing 1
1368561_at +1.45 Abcd2 ATP-binding cassette,
sub-family D (ALD),
member 2
1393320_at +1.45 Utp15 UTP15, U3 small
nucleolar
ribonucleoprotein
1390506_at +1.44 Med1 Mediator complex
subunit 1
1376423_at +1.44 Fbxl19 F-box and leucine-rich
repeat protein 19
1376565_at +1.33 Pde4a Phosphodiesterase 4A
Fold changes were calculated by comparison of the mean expression value in
the 3-month-old recuperated offspring to the age-matched control group.
P<0.05 for all the genes identified.
Table 3. Genes in the ARC that are downregulated in recuperated
3-month-old male rats
Probe set
ID
Fold
change
Gene
symbol Gene name
1387675_at −2.48 Plau Plasminogen activator,
urokinase
1382284_at −2.09 Nek3 NIMA (never in mitosis
gene a)-related
kinase 3
1384767_at −1.80 Usp42 Ubiquitin specific
peptidase 42
1375362_at −1.74 Sppl2a Signal peptide peptidase-
like 2A
1372995_at −1.70 Prkd2 Protein kinase D2
1398431_at −1.67 Car8 Carbonic anhydrase 8
1371770_at −1.63 Pfdn6 Prefoldin 6
1369638_at −1.62 Eef2k Eukaryotic elongation
factor-2 kinase
1370204_at −1.59 Frag1 FGF receptor activating
protein 1
1396268_at −1.58 Sp110 SP110 nuclear body
protein
1391669_at −1.57 Ptprb Protein tyrosine
phosphatase, receptor
type, B
1385871_at −1.54 Dhx36 DEAH (Asp-Glu-Ala-His)
box polypeptide 36
1388030_at −1.48 Gabbr1 Gamma-aminobutyric
acid (GABA) B
receptor 1
1392174_at −1.47 Chst12 Carbohydrate
sulfotransferase 12
1376644_at −1.46 Med19 Mediator complex
subunit 19
1388705_at −1.44 Selm Selenoprotein M
1389123_at −1.44 Ccl6 Chemokine (C-C motif)
ligand 6
1370384_at −1.43 Prlr Prolactin receptor
1372270_at −1.43 Dpagt1 GlcNAc-1-P transferase
1373109_at −1.43 Map2k7 Mitogen activated protein
kinase kinase 7
1375137_at −1.38 Arpc2 Actin related protein 2/3
complex, subunit 2
1393172_at −1.35 Nab1 Ngfi-A binding protein 1
1388088_at −1.34 Usf2 Upstream transcription
factor 2
1397642_at −1.34 Rad50 RAD50 homolog
(S. cerevisiae)
1398242_at −1.34 Ppp5c Protein phosphatase 5,
catalytic subunit
Fold changes were calculated by comparison of the mean expression value in
the 3-month-old recuperated offspring to the age-matched control group.
P<0.05 for all the genes identified.
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Several mechanisms might be involved in mediating the
relationship between reduced maternal circulating tryptophan and
increased 5-HT in the brains of their unborn offspring. In adult rats,
food deprivation leads to an increase in the concentration of
circulating free fraction of tryptophan (FFT), the fraction that passes
through the blood-brain barrier (Knott and Curzon, 1972; Perez-
Cruet et al., 1972). Raised circulating FFT and increases in
tryptophan uptake by serotonergic neurons, the activity of
tryptophan-5-hydroxylase and synthesis of 5-HT have also been
reported in intrauterine growth-restricted (IUGR) rat pups and
infants (Kalyanasundaram, 1976; Hernandez et al., 1989; Manjarrez
et al., 1996, 1998). Upregulation of FFT in IUGR was attributed to
abnormal kinetics of tryptophan binding to albumin (Hernandez-
Rodriguez et al., 2009). Reduced plasma levels of leucine,
isoleucine and tyrosine, which compete with tryptophan for entry
into brain, might also contribute to an increase in the transport of
tryptophan across the blood-brain barrier in IUGR pups (Roux and
Jahchan, 1974).
In recent years, in both mice and humans, the placenta has
emerged as an important source of 5-HT, that can directly impact
fetal brain development (Bonnin et al., 2011). In our study, the
impact of maternal low-protein diet on 5-HT was more pronounced
in the placenta and fetal brain than in the dam. This supports the
proposal that the placenta is cannibalised in response to maternal
food deprivation to provide nutrients and substrates for the
developing hypothalamus (Broad and Keverne, 2011). We
observed an association between levels of placental 5-HT and
fetal brain 5-HT at E16.5 – the time-point at which 5-HT fibres can
be detected in the hypothalamus and both exogenous and
endogenous sources of 5-HT contribute to fetal 5-HT synthesis
(Aitken and Tork, 1988; Bonnin et al., 2011). Increased 5-HT
production within the placenta might contribute to raised 5-HT
Table 4. RMA Plier gene function analysis for recuperated offspring
compared with controls
Category P-value
Cell cycle 7.01E-05
Connective tissue development and function 7.01E-05
Cellular growth and proliferation 1.64E-04
Drug metabolism 1.64E-04
Molecular transport 1.64E-04
Small-molecule biochemistry 1.64E-04
Cancer 1.65E-04
Neurological disease 2.34E-04
Cellular development 3.55E-04
Cellular assembly and organisation 4.88E-04
Fig. 5. Validation of the differentially expressed genes identified using microarray approach as being regulated by early nutrition. (A) Validation of the
differentially expressed genes in the ARC of 3-month-old control and recuperated offspring. Analysis was carried out using Taqman qRT-PCR. Gene expression
data is normalised to Ppia. Data were analysed using a two-tailed unpaired Student’s t-test. (B) Validation of Htr2a mRNA expression in the ARC using ISHH.
(C) Htr2a mRNA expression in rats at P3 and P22 in the ARC. (D) Htr2a mRNA expression in 3-month-old rats in the VMN using ISHH. (E) Htr2a mRNA
expression in 3 and 22 day old rats in the VMN. (F) Localisation of Htr2a on ARC POMC neurons in 3-month-old control rats detected using ISHH for [35S]Htr2a
and chromogenic IHC for α-MSH. Dense black granular staining directly overlapping brown α-MSH cell body and axons indicates the presence ofHtr2a on POMC
neurons. Scale bars: 200 µm for ARC image, 10 µm in the inset. Data were analysed using two-tailed Student’s t-test in B,D; a two-way ANOVA was used with
appropriate Duncan’s post hoc test for C,E. Values are expressed as means±s.e.m. For A,B,D, n=8 per group; for C,E, n=6-8 per group, n represents number of
litters. *P<0.05; **P<0.01. 3V, 3rd ventricle; ME, median eminence.
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levels in fetal brains from low-protein dams. Maternal tryptophan
levels have also been reported to influence central 5-HT levels in the
offspring and maternal peripheral 5-HT proved to be important for
offspring neurodevelopment (Bonnin and Levitt, 2011; Cote et al.,
2007). This suggests that both maternal and placental tryptophan/
5-HT metabolism are part of an important molecular pathway for
fetal programming of the 5-HT system and brain development.
Changes in 5-HT bioavailability not only impact formation of
hypothalamic circuitry during development but have also been
shown to influence appetite and body mass in the adult (Pôrto et al.,
2009; Berg et al., 2013; Madden and Zup, 2014). 5-HT primarily
regulates energy balance via activity at the Gq-coupled receptor,
5-HT2CR. Here we report that elevated fetal 5-HT could potentially
programme decreased levels of hypothalamic 5-HT2CR, although
direct evidence for this relationship remains to be established.
The reduction in 5-HT2CR could be an early and permanent
developmental consequence of central hyperserotonemia. Reduced
5-HT2CR function is known to promote increased appetite and
obesity. Specifically, genetic inactivation of Htr2c, leads to lifelong
hyperphagia and elevated body mass in mice fed standard chow diet
(Tecott et al., 1995), whereas pharmacological activation of these
receptors reduces food intake and decreases body mass (Heisler
et al., 2002; Halford and Harrold, 2012; Burke et al., 2014).
5-HT2CRs are involved in mediating the action of D-fenfluramine,
which stimulates the release of 5-HT and inhibits the re-uptake of
5-HT into nerve terminals (Vickers et al., 2001; Trifunovic and
Reilly, 2006; Xu et al., 2010). Moreover, the subpopulation of
5-HT2CRs expressed solely with POMC is sufficient to mediate
D-fenfluramine and 5-HT2CR agonist mCPP appetite suppression
(Xu et al., 2008). Following the administration of D-fenfluramine
into the third ventricle, we observed impaired sensitivity to 5-HT-
stimulated food reduction in 3-month-old recuperated animals. As
the functional capacity of 5-HT2CR is dependent upon availability
of active membrane receptor pools, the impaired response to
D-fenfluramine in recuperated animals is probably a consequence of
reduced 5-HT2CR protein levels in the hypothalamus of these
animals.
We used LCM of the ARC combined with microarray analysis to
identify differentially expressed genes that could be affected by
early hyperserotonemia. We found that Khsrp expression was
increased in 3-month-old recuperated offspring. Khsrp, which
encodes KH-type splicing regulatory protein, is involved in the
control of mRNA decay (Gherzi et al., 2006; Ruggiero et al., 2007)
and plays a key role in the translation of DNA damage signalling to
miRNA biogenesis (Trabucchi et al., 2009; Zhang et al., 2011).
Although recuperated animals have reduced longevity (Jennings
et al., 1999), which is associated with increased oxidative stress and
an impaired response to DNA damage (Tarry-Adkins et al., 2008,
2009), the functional significance of the increase in KHSRP in the
brain of these animals remains to be determined.
Htr2a is another gene that was increased in the 3-month-old
recuperated offspring. The precise role that Htr2a plays in the
regulation food intake has not been fully defined. Htr2a was
upregulated in the ARC of diet-induced obese rats (Park et al.,
1999), whereas in humans, 5-HT2AR correlated positively with BMI
and a polymorphism in the gene encoding 5-HT2AR has been
associated with obesity (Rosmond et al., 2002; Erritzoe et al., 2009;
Carr et al., 2013). However, knockout of Htr2a in mice does not
alter food consumption or gain in body mass when mice are fed
laboratory chow (Weisstaub et al., 2006), suggesting the presence of
developmental compensatory mechanisms or that body mass gain
only occurs when these mice are placed on an obesogenic diet.
There is little information regarding the precise neuronal location of
5-HT2AR within the ARC. Here, we report that 5-HT2ARs, like
5-HT2CRs (Heisler et al., 2002; Lam et al., 2008), are anatomically
positioned to influence the activity of the critical energy balance
regulator POMC. The extent to which the activity of POMC neurons
can be influenced by action at 5-HT2ARs and whether this
mechanism is altered in recuperated offspring as well as direct
evidence for linking fetal hyperserotonemia to alteration of
5-HT2AR in later life remain to be established.
Because Htr2a expression was increased in the ARC of
recuperated pups at weaning and in adulthood, but not in brains
of fetuses or neonates, the differences in 5-HT2AR must be
established during the period of catch-up growth, between P3 and
P22, much later then the observed differences in 5-HT2CR levels.
Therefore, upregulation of 5-HT2AR might act as a secondary,
counter-regulatory response to impaired 5-HT2CR signalling.
Counter-regulatory mechanisms have been reported among 15
existing 5-HT receptor subtypes as genetic alteration of one specific
5-HT receptor subtype can result in compensatory signalling
through another; for example, signalling through 5-HT1BR in the
absence of 5-HT2CR (Heisler and Tecott, 2000; Dalton et al., 2004).
It is possible that counter-regulatory upregulation of 5-HT2AR in
response to impaired signalling through 5-HT2CR only emerges
when growth-restricted newborn pups are born into and exposed
postnatally to an environment of plentiful food. Some effects of
early alterations in 5-HT therefore, might only appear in the
presence of a particular postnatal environment. This has been shown
to be true in a study of 3-month-old infants exposed to a selective
serotonin reuptake inhibitor, where altered HPA stress response
patterns only became apparent when the method of infant feeding
was taken into consideration (Oberlander et al., 2008).
5-HT2AR stimulation by administration of agonists produced a
greater effect on appetite in recuperated rats, revealing that the
overexpressed ARC 5-HT2ARs are functional. As pharmacological
stimulation of endogenous 5-HT was less effective in suppressing
appetite in recuperated rats, these results suggest that the
endogenous circuitry is insufficient to appropriately modulate
5-HT-regulated appetite. However, this change in endogenous
programming might be circumvented and the upregulation of the
5-HT2AR capitalised upon by pharmacological treatment with a
5-HT2AR non-hallucinogenic agonist. The anorectic therapeutic
profile could be potentially further improved by combining the
dose of TCB-2 (nmoles)
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Fig. 6. Effects of maternal protein restriction on food intake following
central administration of the 5-HT2AR agonist TCB2 in 3-month-old rats.
Food consumption during the 2 h following lights out expressed as a
percentage of the saline dosed group. Differences between the groups were
analysed using two-way ANOVA (overall effect of TCB2 administration,
P<0.001; overall effect of early nutrition, P<0.05) followed by Bonferroni’s
multiple comparison test. n=13-15 per group, n represents number of litters.
*P<0.05.
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5-HT2AR agonist, with 5-HT2CR and 5-HT1BR agonists, because
co-application of 5-HT2CR and 5-HT1BR agonists produced a
significant increase in the activity of POMC in the ARC (Doslikova
et al., 2013). Development of a non-hallucinogenic 5-HT2AR
agonist might seem to be challenging. However, studies showing
that the glutamate mGlu2 receptor heterocomplex with 5-HT2AR,
and not 5-HT2AR on its own, acts as a molecular target for the
actions of hallucinogenic drugs provide a plausible avenue to
explore in the development of therapeutically suitable 5-HT2AR
agonists (Moreno et al., 2011).
Although we concentrated on studying mechanisms that could
mediate the effects of early elevated 5-HT levels on obesity risk in
later life, early perturbations in the 5-HT neurotransmitter system
are known to have major implications for mental health and
behaviour in childhood and adulthood. Increased anxiety-like
behaviour in nonhuman primate offspring of dams fed a high-fat
diet was associated with perturbations in the 5-HT system during
fetal life (Sullivan et al., 2010). Early hyperserotonemia, in
particular, has been identified as a potential factor in the
pathogenesis of autism spectrum disorder and schizophrenia
(Chugani, 2004; Madden and Zup, 2014). In addition, both
5-HT2AR and 5-HT2CR, which are expressed throughout the
brain, have been implicated in the pathophysiology of psychiatric
disorders (Abramowski et al., 1995; Hoyer et al., 1986; Heisler
et al., 2007; Mestre et al., 2013; Lyddon et al., 2013). 5-HT2CR, for
example, was shown to play a role in addiction and reward
behaviour by modulating dopamine transmission within the
mesolimbocortical dopaminergic system (Katsidoni et al., 2011).
Dysregulation of the reward-related neurotransmitter systems and
behaviours could also contribute to the increased susceptibility to
obesity in the recuperated offspring (Grissom et al., 2014).
In summary, we report that elevated 5-HT in fetuses exposed to
maternal protein restriction, might underlie a permanent reduction in
5-HT2CR expression and function and secondary counter-regulatory
upregulation of 5-HT2AR and increased sensitivity to 5-HT2AR
agonists. Thus, our results not only identify a molecular mechanism
through which maternal diet might impair offspring energy balance,
but also point to a promising pharmacological strategy with
5-HT2AR agonist medication to correct this impairment.
MATERIALS AND METHODS
Experimental groups and tissue collection
All procedures involving animals were conducted in accordance with the
University of Cambridge and the University of Buckingham project licences
under the UK Home Office Animals (Scientific Procedures) Act (1986).
The breeding of animals was conducted at both the University of Cambridge
and the University of Buckingham. Five cohorts of Wistar rats (Rattus
norvegicus) were established for the studies. One for E16.5 experimental
measures, the second for laser-capture microdissection (LCM) and
microarray validations, the third for in situ hybridisation, the fourth for
intracerebroventricular (i3v) and 5-HT/tryptophan measurements and the
fifth for protein andmRNA analysis. Detailed information regarding the diet
composition and the set-up of the maternal protein restricted and control
dams have been published previously (Cripps et al., 2009; Berends et al.,
2013). Briefly, on P3, two experimental groups of offspring were
established: controls [offspring of control dams (20% protein, w/v), culled
to eight (four males and four females) suckled by control dams] and
recuperated [offspring of dams fed a low-protein diet (8% protein, w/v)
during pregnancy, but nursed by control dams, culled to four males to
maximise the plane of nutrition]. The animals were allocated to
experimental groups at random. Whole heads were collected from fetuses
at E16.5 of pregnancy and from male pups at P3. In addition, hypothalami
were dissected from brains of male offspring at P3. The body weight of the
remaining pups was recorded at P7, P14 and P21. Following weaning at day
22, one male per litter was culled by a rising concentration of CO2 and the
brain was dissected. After weaning, the remaining males were fed standard
laboratory chow and body mass and food intake were recorded weekly. At
3 months, males were culled and brains were collected. All the dissected
brains and heads were frozen on powdered dry ice and were stored at −80°C
until further processing. Amniotic fluid and placentas were harvested at
E16.5 and serum was prepared from the dams and male pups at P3, weaning
and 3 months, and stored at −80°C prior to the measurement of 5HT and
tryptophan levels.
5-HT and tryptophan assay
Whole brains, placentas, amniotic fluid and serum were used for
measurement of 5-HT (DRG International) and tryptophan (Abnova) by
ELISA, following the manufacturer’s recommendation for sample
preparation, acylation (5-HT) and derivatisation (tryptophan). For the
measurement of 5-HT in tissue, hypothalamic blocks were excised from
frozen brains and extracted as described (Huang et al., 2012). Briefly,
samples were homogenised and deproteinised for 30 min in 0.2 N perchloric
acid solution containing 7.9 mM Na2S2O5 and 1.3 mM disodium
ethyleneamine-tetra-acetic acid. The homogenate was centrifuged at
10,000 g for 10 min at 4°C and the supernatant assayed for 5-HT.
Feeding studies
Animals were cannulated as described previously (Stocker et al., 2012).
Briefly, a cannula was inserted into the third ventricle under a gaseous
anaesthetic (isofluorane: Isoba, Schering-Plough Animal Health) using
coordinates from the stereotactic rat brain atlas (Paxinos andWatson, 1998).
Its position was verified by a positive drinking response over 15 min to
angiotensin II (20 µg ml−1 in 2.5 µl). For measurements of acute effects of
D-fenfluramine or 5-HT2AR agonism on food intake, 3-month-old rats were
individually housed, fasted for 4 h, dosed at the beginning of the 12 h dark
period and re-fed. Peptide (250 nmol) was given in 2.5 µl saline. Animals
were dosed using a Latin square design. Doses were separated by at least
4 days and normal feeding behaviour and body mass was restored prior
to administration of the next dose. The specificity and doses of the
D-fenfluramine (Tocris Bioscience), or the high-affinity 5-HT2AR receptor
agonist TCB2 (Tocris Bioscience) were based on published data (Vickers
et al., 1999, 2001; Trifunovic and Reilly, 2006; McLean et al., 2006; Xu
et al., 2010; Fox et al., 2010) and doses were optimised.
Western blotting
Hypothalami were dissected from frozen brains according to landmarks:
anterior to the optic chiasma, posterior to the mammillary bodies, lateral at
the hypothalamic sulcus and superior to the anterior commissure. Dissected
hypothalami from P3 and 3-month-old male offspring were homogenised in
TK lysis buffer and western blotting analysis was carried out as previously
described (Martin-Gronert et al., 2008). Anti-goat primary antibody against
5-HT2CR purchased from Santa Cruz Biotechnology (sc-15081, lot D1114)
was used at 1:200 dilution. The antibody was validated in two previous
studies (Bubar et al., 2005; Anastasio et al., 2010). Anti-goat horseradish
peroxidase-conjugated secondary antibody (Jackson ImmunoResearch) was
used at 1:10,000 dilution.
Laser-capture microdissection, RNA isolation and analysis
Hypothalamic sections of the ARC were prepared on a cryostat at 14 µm
thickness from approximately −4.52 to −2.30 mm relative to Bregma
(Paxinos and Watson, 1998). Sections were collected onto RNase-free
membrane-coated slides (PALM Microlaser Technologies) that had been
baked at 200°C for 4 h and UV cross-linked for 30 min. Within 24 h of
sectioning, sections were placed for 30 s each time in 95%, 75% and 50%
ethanol for rehydration. Sections were stained with 1% Cresyl Violet stain
(Ambion) for 1 min, dehydrated in graded ethanol concentrations (50%,
75% and twice in 100% for 30 s each time), placed in HistoClear (National
Diagnostics) for 5 min and air dried. LCM was performed using a PALM
MicrolaserSystem (Fig. 4A). Following microdissection, the captured cells
were kept in RNAlater (Ambion). Total RNA was isolated from LCM
samples using the RNAqueous Micro RNA extraction kit (Ambion) in
accordancewith the manufacturer’s protocol. The quality and quantity of the
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RNA samples was determined using Agilent BioAnalyzer PicoChips
(Agilent Technologies). Total RNAwas isolated from E16.5 fetal heads and
neonatal and adult (3 months of age) hypothalami as previously described
(Zaibi et al., 2010) and analysed using a NanoDropND1000 (Thermo Fisher
Scientific).
RNA amplification
An ovation Pico RNA Amplification System (Nugen Technologies) was
used for the amplification of RNA destined for microarray analysis. RNA
amplification of LCM ARC samples used to validate genes identified by
microarray analysis was performed using a MegaScript T7 Amplification
Kit (Ambion) in combination with the GeneChip sample CleanUp Module
kit (Affymetrix). The use of a different method of RNA amplification
enhanced the validation of the microarray data.
Microarray hybridisation
The amplified RNA was used for gene expression profiling on Affymetrix
Rat Genome 230 2.0 Arrays (Affymetrix) using the Affymetrix GeneChip
protocol to fragment and label the target, ready for hybridisation to the arrays
(Affymetrix 2004). GeneChip sequences were selected from GenBank,
dbEST and RefSeq and the sequence clusters created using UniGene were
then further refined by comparison with the publicly available assembly of
the rat genome. Microarray hybridisation was carried out by Molecular
Biology Services at the University of Warwick, using n=6 chips per group.
Microarray analysis and selection of the genes for validation
Raw image data files were converted to CEL and pivot files using
Affymetrix GeneChip Operating Software. All downstream analysis of
microarray data was performed using GeneSpring GX 12.0 (Agilent). The
CEL files were used for the RMA (Irizarry et al., 2003) and GC-RMA
(Wu et al., 2004) analyses, whereas the pivot files were used for GCOS
analysis. After importing the data, each chip was normalised to the 50th
centile of the measurement taken from that chip and all gene expression
data reported as a fold-change from the control state. Genes were
considered to be up- or downregulated if the 1.3-fold threshold was
reached and P<0.05. Only genes that met the above criteria using three
different algorithms: GCOS, RMA and GCRMA were taken forward for
additional study. The further selection of genes for validation was based
on the function of the gene and the availability of suitable primers for
validation. Functional analysis was performed using Ingenuity Pathway
Analysis (Ingenuity Systems).
Validation of microarray data using Taqman RT-PCR
Validation of the microarray data was carried out using Micro Fluidic Cards
(Applied Biosystems) in accordance with the manufacturer’s protocol. The
reactions were performed in duplicate for each sample using an ABI
7900HT (Applied Biosystems). A standard curve was constructed for each
gene using a serial dilution of pooled cDNA from all LCM ARC samples.
The mean CT values of the experimental samples were then used to calculate
the relative expression for each sample. The data was normalised to Ppia
(cyclophilin) expression, which did not change between maternal treatment
groups. Real-time PCR (StepOne, Applied Biosystems) was carried out
using Assay-on-Demand pre-designed primer and probe sets (Applied
Biosystems). Data were analysed using the comparative ΔCT method,
comparing recuperated animals with controls. All procedures were carried
out in accordance with the manufacturer’s recommendation.
In situ hybridisation histochemistry
Coronal sections (20 µm) of frozen hypothalamic ARC, obtained using a
cryostat, were thaw-mounted onto poly-L-lysine slides (Polysine, Menzel
Glaser, Braunschweig, Germany). Ten sets of slides per animal were serially
collected,with the first set of 10 beginning at approximately−4.52 and ending
at −2.12 mm, relative to Bregma, according to the atlas of the rat brain
(Paxinos and Watson, 1998). For the sectioning of neonatal rat brains, whole
heads were used and the sectioning was guided by the neonatal rat brain atlas
(Ramachandra andSubramanian, 2011). Slideswere stored at−80°Cuntil use.
A [35S]-radiolabelled riboprobe targeting nucleotides 1700-1910 of
the rat Htr2a mRNA transcript was generated by PCR from whole rat
brain cDNA. The 210 bp fragment was cloned into pCR-TOPO4 (Life
Technologies). For antisense probe generation, PstI linearised recombinant
plasmid was subjected to in vitro transcription using T7 polymerase in the
presence of 35S-labelled UTP, as per the manufacturer’s instructions
(Ambion). The ISHH procedure used has been described in detail
previously (Alon et al., 2009; Garfield et al., 2012). Autoradiographic
images were quantified using Image Proplus software (Media Cybernetics).
Standard curves were generated from 14C autoradiographic microscales
(Amersham) and integrated optical density (IOD) and area of the
hybridisation signal were measured. For each animal, 3-5 sections of
ARC (−4.52 mm to −2.12 mm from Bregma) and 2-3 sections for VMN
(−3.60 mm to −2.12 mm from Bregma) were analysed. Average ARC and
VMH Htr2a mRNA expression was calculated.
Dual-label ISHH and immunohistochemistry
To assess colocalisation of 5-HT2AR and POMC, brains taken from control
rats, were first processed for detection ofHtr2amRNAby ISHH, as described
above. Following this, the tissue was washed in PBS before commencement
of the IHC protocol to label α-melanocyte-stimulating hormone (α-MSH)
protein using procedures previously described (Alon et al., 2009; Garfield
et al., 2012). Briefly, sections were incubated in 0.3% H2O2 in PBS, then
rinsed in PBS, blocked in 0.5% BSA/0.5% Triton X-100 in PBS and left in
blocking buffer containing rabbit α-MSH antibody (1/10,000; Chemicon,
Millipore, MA, USA) overnight. Tissue was then washed in PBS and a
biotinylated donkey anti-rabbit secondary antibody (Vector Laboratories) was
applied at 1:1000 in blocking buffer. Sections were then washed in PBS,
incubated in VectaStain ABC reagent, and following this, chromogenic
detection was conducted using 3,3′-diaminobenzidine (DAB) reagent
(Vector Laboratories). Sections were mounted onto superfrost slides, dried,
then dipped in photographic emulsion (Kodak) and stored at 4°C for 2 weeks
before being developed using Kodak developer and fixer. Double-labelled
cells were recorded if α-MSH-immunoreactive (IR) cell bodies were overlaid
with a [35S]Htr2a signal greater than 3× background.
Statistical analysis
Two-tailed unpaired Student’s t-test was used for statistical analysis and the
data are presented as means±s.e.m. unless otherwise stated. Fractional growth
rates were calculated using formula: fractional growth rate=(current−starting
mass)/(period×starting mass). For microarray data P-values were calculated
using a two-tailed t-test. All data were analysed using GraphPad Prism.
Number (n) refers to number of litters used. P<0.05 was considered
statistically significant.
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